Results 211 to 220 of about 23,218 (270)

Computer-aided design enables repurposing of proprotein convertase subtilisin/kexin type 9 degrader from cholesterol-lowering to colon cancer therapy. [PDF]

Mol Biomed
Fan G, Zha J, Chen S, Cang P, Zhang Q, Yang J, Liu M.   +6 more
europepmc   +1 more source

Evolocumab-induced allergic reaction in a post-partial gastrectomy patient: A case report. [PDF]

Medicine (Baltimore)
Hong X, Jiang X, Xu X, Xiong F, Huang X.
europepmc   +1 more source

Inclisiran-Induced Fixed Drug Eruption in a Patient With Refractory Hypercholesterolemia. [PDF]

Cureus
Khan JA, Shahab S.
europepmc   +1 more source

RETRACTION: Intelligent Algorithm-Based Ultrasound Images in Evaluation of Therapeutic Effects of Radiofrequency Ablation for Liver Tumor and Analysis on Risk Factors of Postoperative Infection. [PDF]

Contrast Media Mol Imaging
Imaging CMM.
europepmc   +1 more source

Remnant cholesterol in chronic obstructive pulmonary disease-phenotypes and pharmacotherapy matter. [PDF]

J Thorac Dis
Hao J, Gu X.
europepmc   +1 more source

Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Han L, Su C, Lian R, Han J, Fan X, Gao L.   +5 more
europepmc   +1 more source

2025 Egyptian guidelines for the management of dyslipidemia. [PDF]

Egypt Heart J
Reda A, Taha HS, Badran HM, Khamis H, Kamal S, Elserafy AS, Dawoud MH, Elamragy AA, Bendary A, Shaker MM.   +9 more
europepmc   +1 more source

Anthropometric indices and mortality in postmenopausal women: NHANES 1999-2018 evidence. [PDF]

BMC Womens Health
Wang K, Li Y, Chen Y.
europepmc   +1 more source